| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.7M | -64.8% |
| Cost of Revenue | $8.8M | -66.7% |
| Gross Profit | $1.07B | +0.0% |
| R&D Expense | $429K | -46.3% |
| SG&A Expense | $4.0M | -27.2% |
| Operating Income | -$4.8M | +58.1% |
| Pre-tax Income | -$6.0M | +51.6% |
| Income Tax | $12K | -65.7% |
| Net Income | -$6.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20K | -98.4% |
| Accounts Receivable | $1.1M | -65.7% |
| Current Assets | $1.5M | -74.7% |
| Total Assets | $2.0M | -80.5% |
| Current Liabilities | $7.1M | -12.9% |
| Total Liabilities | $7.1M | -25.6% |
| Stockholders' Equity | -$5.1M | -1050.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | +32.9% |
| Capital Expenditures | $12K | -7.7% |
| Investing Cash Flow | -$12K | +7.7% |
| Financing Cash Flow | -$133K | -108.8% |
| Free Cash Flow | -$1.1M | +32.7% |
| +51.6% |
| EPS (Basic) | -$1.13 | +61.3% |
| EPS (Diluted) | -$1.13 | +61.3% |